The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
Open accessAbstract
&NA; Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) comprise a category of versatile drug delivery systems that have been used in the biomedical field for >25 years. SLNs and NLCs have been used for the treatment of various diseases including cardiovascular and cerebrovascular, and are considered a standard treatment for the latter, due to their inherent ability to cross the blood brain barrier (BBB). In this review, a presentation of the most important brain diseases (brain cancer, ischemic stroke, Alzheimer's disease, Parkinson's disease and multiple sclerosis) is approached, followed by the basic fabrication techniques of SLNs and NLCs. A detailed description of the reported studies of the last seven years, of active and passive targeting SLNs and NLCs for the treatment of glioblastoma multiforme and of other brain cancers, as well as for the treatment of neurodegenerative diseases is also carried out. Finally, a brief description of the advantages, the disadvantages, and the future perspectives in the use of these nanocarriers is reported, aiming at giving an insight of the limitations that have to be overcome in order to result in a delivery system with high therapeutic efficacy and without the limitations of the existing nano‐systems. Graphical abstract A multi‐functional nanostructured lipid carrier (M‐NLC) can penetrate the blood brain barrier (BBB) after proper surface functionalization and deliver its therapeutic cargo in the diseased tissue. Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlled growth of monodisperse silica spheres in the micron size range
Stöber, W., Fink, A., & Bohn, E. (1968) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(68)90272-5 · Cited by 14,532
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Pharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Primary brain tumours in adults
Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., & Delattre, J.-Y. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61346-9 · Cited by 1,201
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Interrater Reliability of the NIH Stroke Scale
Goldstein, L. B., Bertels, C., & Davis, J. N. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420080026 · Cited by 986
Mehnert, W., & Mäder, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.021 · Cited by 981
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.130965 · Cited by 679
Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy
Qin, W., Huang, G., Chen, Z., & Zhang, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00001 · Cited by 656
Gene delivery by lipoplexes and polyplexes
Tros de Ilarduya, C., Sun, Y., & Düzgüneş, N. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.019 · Cited by 627
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
Dahlman, J. E., Barnes, C., Khan, O. F., Thiriot, A., Jhunjunwala, S., Shaw, T. E., Xing, Y., Sager, H. B., Sahay, G., Speciner, L., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.84 · Cited by 592
Ceria Nanoparticles that can Protect against Ischemic Stroke
Kim, C. K., Kim, T., Choi, I., Soh, M., Kim, D., Kim, Y., Jang, H., Yang, H., Kim, J. Y., Park, H., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203780 · Cited by 585
Das, S., Ng, W. K., & Tan, R. B. H. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.05.010 · Cited by 576
Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
Cardoso, F. L., Brites, D., & Brito, M. A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.003 · Cited by 569
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 565
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Nanoparticles for Brain Drug Delivery
Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 489
Lipid‐based nanotherapeutics for siRNA delivery
Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447
Vieira, D., & Gamarra, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117210 · Cited by 427
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Niosomes: A Controlled and Novel Drug Delivery System
Rajera, R., Nagpal, K., Singh, S. K., & Mishra, D. N. (2011) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.34.945 · Cited by 415
Niosomes as Nanoparticular Drug Carriers: Fundamentals and Recent Applications
Ag Seleci, D., Seleci, M., Walter, J.-G., Stahl, F., & Scheper, T. (2016) · Journal of Nanomaterials · doi:10.1155/2016/7372306 · Cited by 406
Challenges in Development of Targeted Liposomal Therapeutics
Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 379
Agrawal, M., Ajazuddin, Tripathi, D. K., Saraf, S., Saraf, S., Antimisiaris, S. G., Mourtas, S., Hammarlund-Udenaes, M., & Alexander, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.019 · Cited by 356
Brain cancer diagnosis and therapy with nanoplatforms☆
KOO, Y., REDDY, G., BHOJANI, M., SCHNEIDER, R., PHILBERT, M., REHEMTULLA, A., ROSS, B., & KOPELMAN, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.012 · Cited by 326
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Fonseca-Santos, B., Chorilli, M., & Palmira Daflon Gremião, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 308
Gelperina, S., Maksimenko, O., Khalansky, A., Vanchugova, L., Shipulo, E., Abbasova, K., Berdiev, R., Wohlfart, S., Chepurnova, N., & Kreuter, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.003 · Cited by 293
Spray-drying of solid lipid nanoparticles (SLNTM)
Freitas, C., & Müller, R. H. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00172-0 · Cited by 282
Tiwari, R., & Pathak, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.044 · Cited by 261
Dhawan, S., Kapil, R., & Singh, B. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01225.x · Cited by 256
Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization
Joh, D. Y., Sun, L., Stangl, M., Al Zaki, A., Murty, S., Santoiemma, P. P., Davis, J. J., Baumann, B. C., Alonso-Basanta, M., Bhang, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062425 · Cited by 252
Sá Santos, S., Santos, S. M., Pinto, A. R. T., Ramu, V. G., Heras, M., Bardaji, E., Tavares, I., & Castanho, M. A. R. B. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00001 · Cited by 250
Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery
Chen-yu, G., Chun-fen, Y., Qi-lu, L., Qi, T., Yan-wei, X., Wei-na, L., & Guang-xi, Z. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.042 · Cited by 247
Madane, R. G., & Mahajan, H. S. (2016) · Drug Delivery · doi:10.3109/10717544.2014.975382 · Cited by 241
Jose, S., Anju, S. S., Cinu, T. A., Aleykutty, N. A., Thomas, S., & Souto, E. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.003 · Cited by 237
Tapeinos, C., & Pandit, A. (2016) · Advanced Materials · doi:10.1002/adma.201505376 · Cited by 237
Self-citationNanoparticles Targeting the Infarcted Heart
Dvir, T., Bauer, M., Schroeder, A., Tsui, J. H., Anderson, D. G., Langer, R., Liao, R., & Kohane, D. S. (2011) · Nano Letters · doi:10.1021/nl2025882 · Cited by 230
Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parmar, G. R. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.03.002 · Cited by 223
Kakkar, V., Muppu, S. K., Chopra, K., & Kaur, I. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.02.005 · Cited by 222
Bone mineral density, adiposity, and cognitive functions
Sohrabi, H. R., Bates, K. A., Weinborn, M., Bucks, R. S., Rainey-Smith, S. R., Rodrigues, M. A., Bird, S. M., Brown, B. M., Beilby, J., Howard, M., et al. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00016 · Cited by 222
Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219
Fornaguera, C., Dols-Perez, A., Calderó, G., García-Celma, M. J., Camarasa, J., & Solans, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.002 · Cited by 218
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis
Yang, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0141-7 · Cited by 210
Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
Gobbi, M., Re, F., Canovi, M., Beeg, M., Gregori, M., Sesana, S., Sonnino, S., Brogioli, D., Musicanti, C., Gasco, P., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.044 · Cited by 192
A critical review of lipid-based nanoparticles for taxane delivery
Feng, L., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.006 · Cited by 191
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
Patel, S., Chavhan, S., Soni, H., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2010.523787 · Cited by 186
Cohen, Z. R., Ramishetti, S., Peshes-Yaloz, N., Goldsmith, M., Wohl, A., Zibly, Z., & Peer, D. (2015) · ACS Nano · doi:10.1021/nn506248s · Cited by 182
Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems
Bose, S., Du, Y., Takhistov, P., & Michniak-Kohn, B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.12.013 · Cited by 178
Spuch, C., & Navarro, C. (2011) · Journal of Drug Delivery · doi:10.1155/2011/469679 · Cited by 177
Gold‐Nanoparticle‐Based Multifunctional Amyloid‐β Inhibitor against Alzheimer’s Disease
Gao, N., Sun, H., Dong, K., Ren, J., & Qu, X. (2015) · Chemistry – A European Journal · doi:10.1002/chem.201404562 · Cited by 177
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 177
Meng, F., Asghar, S., Gao, S., Su, Z., Song, J., Huo, M., Meng, W., Ping, Q., & Xiao, Y. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.06.025 · Cited by 176
Bondì, M. L., Craparo, E. F., Giammona, G., & Drago, F. (2010) · Nanomedicine · doi:10.2217/nnm.09.67 · Cited by 175
Yusuf, M., Khan, M., Khan, R. A., & Ahmed, B. (2013) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.747529 · Cited by 171
Dendrimer Advances for the Central Nervous System Delivery of Therapeutics
Xu, L., Zhang, H., & Wu, Y. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400182z · Cited by 167
Martins, S., Costa-Lima, S., Carneiro, T., Cordeiro-da-Silva, A., Souto, E. B., & Ferreira, D. C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.032 · Cited by 165
Zanotto-Filho, A., Coradini, K., Braganhol, E., Schröder, R., de Oliveira, C. M., Simões-Pires, A., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., Forcelini, C. M., et al. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.019 · Cited by 161
Targeted Nanotechnology in Glioblastoma Multiforme
Glaser, T., Han, I., Wu, L., & Zeng, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00166 · Cited by 155
Gabal, Y. M., Kamel, A. O., Sammour, O. A., & Elshafeey, A. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.025 · Cited by 151
In Vivo Specific Delivery of c-Met siRNA to Glioblastoma Using Cationic Solid Lipid Nanoparticles
Jin, J., Bae, K. H., Yang, H., Lee, S. J., Kim, H., Kim, Y., Joo, K. M., Seo, S. W., Park, T. G., & Nam, D. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200406n · Cited by 149
Functional lipids and lipoplexes for improved gene delivery
Zhang, X., McIntosh, T. J., & Grinstaff, M. W. (2011) · Biochimie · doi:10.1016/j.biochi.2011.05.005 · Cited by 148
Martins, S. M., Sarmento, B. F. C. C., Nunes, C., Lúcio, M., Reis, S., & Ferreira, D. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.011 · Cited by 142
Alam, T., Pandit, J., Vohora, D., Aqil, M., Ali, A., & Sultana, Y. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.945416 · Cited by 138
Tsai, M.-J., Huang, Y.-B., Wu, P.-C., Fu, Y.-S., Kao, Y.-R., Fang, J.-Y., & Tsai, Y.-H. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22285 · Cited by 137
Qu, J., Zhang, L., Chen, Z., Mao, G., Gao, Z., Lai, X., Zhu, X., & Zhu, J. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1189465 · Cited by 137
Novel Delivery Strategies for Glioblastoma
Zhou, J., Atsina, K., Himes, B. T., Strohbehn, G. W., & Saltzman, W. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318244d8ae · Cited by 130
Varshosaz, J., Eskandari, S., Minaiyan, M., & Tabbakhian, M. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15881 · Cited by 129
Huang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03124 · Cited by 127
Vedagiri, A., & Sumathi, T. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.03.002 · Cited by 127
Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging
Cherukula, K., Lekshmi, K. M., Uthaman, S., Cho, K., Cho, C.-S., & Park, I. (2016) · Nanomaterials · doi:10.3390/nano6040076 · Cited by 127
Wu, M., Fan, Y., Lv, S., Xiao, B., Ye, M., & Zhu, X. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1058434 · Cited by 126
Yu, D., Khan, O. F., Suvà, M. L., Dong, B., Panek, W. K., Xiao, T., Wu, M., Han, Y., Ahmed, A. U., Balyasnikova, I. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701911114 · Cited by 126
Kuo, Y., & Liang, C.-T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.048 · Cited by 125
Chen, Y., Pan, L., Jiang, M., Li, D., & Jin, L. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1049719 · Cited by 122
Liu, L., Tang, Y., Gao, C., Li, Y., Chen, S., Xiong, T., Li, J., Du, M., Gong, Z., Chen, H., et al. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.11.029 · Cited by 122
Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 120
Silva, A. C., Kumar, A., Wild, W., Ferreira, D., Santos, D. F. G., & Forbes, B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.058 · Cited by 118
Sachdeva, A. K., Misra, S., Kaur, I. P., & Chopra, K. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.014 · Cited by 117
Singh, S. K., Dadhania, P., Vuddanda, P. R., Jain, A., Velaga, S. P., & Singh, S. K. (2016) · RSC Advances · doi:10.1039/c5ra19793g · Cited by 117
Kakkar, V., Mishra, A. K., Chuttani, K., & Kaur, I. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.046 · Cited by 114
Zhao, Y., Li, X., Lu, C., Lin, M., Chen, L., Xiang, Q., Zhang, M., Jin, R., Jiang, X., Shen, X., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.10.009 · Cited by 114
Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles
Lu, Y., Huang, J.-Y., Wang, H., Lou, X.-F., Liao, M.-H., Hong, L.-J., Tao, R., Ahmed, M. M., Shan, C.-L., Wang, X.-L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.093 · Cited by 113
Song, S., Mao, G., Du, J., & Zhu, X. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1064186 · Cited by 112
In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma
de Mendoza, A. E., Véronique Préat, A., Mollinedo, F., & Blanco‐Prieto, M. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.030 · Cited by 112
Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems
Dolatabadi, J. E. N., & Omidi, Y. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.12.016 · Cited by 106
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles
Venishetty, V. K., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.003 · Cited by 104
Hinkle, J. L., & Guanci, M. M. (2007) · Journal of Neuroscience Nursing · doi:10.1097/01376517-200710000-00005 · Cited by 101
Battaglia, L., Gallarate, M., Peira, E., Chirio, D., Muntoni, E., Biasibetti, E., Capucchio, M. T., Valazza, A., Panciani, P. P., Lanotte, M., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24002 · Cited by 98
Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Serpe, L., & Trotta, M. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.590615 · Cited by 98
Pardeshi, C. V., Belgamwar, V. S., Tekade, A. R., & Surana, S. J. (2013) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-4965-7 · Cited by 97
CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery
Zhao, J., Zhang, B., Shen, S., Chen, J., Zhang, Q., Jiang, X., & Pang, Z. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.03.019 · Cited by 96
Lipid nanoparticles: perspectives and challenges☆
Gasco, M. R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.004 · Cited by 96
Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System
Craparo, E. F., Bondì, M. L., Pitarresi, G. L., & Cavallaro, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00199.x · Cited by 95
Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Muntoni, E., Riganti, C., Biasibetti, E., Capucchio, M. T., Valazza, A., Panciani, P. P., et al. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.017 · Cited by 94
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Montenegro, L., Campisi, A., Sarpietro, M., Carbone, C., Acquaviva, R., Raciti, G., & Puglisi, G. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.539231 · Cited by 92
Alam, M. I., Baboota, S., Ahuja, A., Ali, M., Ali, J., & Sahni, J. K. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.05.014 · Cited by 91
Esteves, M., Cristóvão, A. C., Saraiva, T., Rocha, S. M., Baltazar, G., Ferreira, L., & Bernardino, L. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00020 · Cited by 88
Kuo, Y., & Cheng, S.-J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.054 · Cited by 87
Battaglia, L., Gallarate, M., Peira, E., Chirio, D., Solazzi, I., Giordano, S., Gigliotti, C. L., Riganti, C., & Dianzani, C. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/25/255102 · Cited by 85
Costa, P. M., Cardoso, A. L., Nóbrega, C., Pereira de Almeida, L. F., Bruce, J. N., Canoll, P., & Pedroso de Lima, M. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds496 · Cited by 80
Griveau, A., Béjaud, J., Anthiya, S., Avril, S., Autret, D., & Garcion, E. (2013) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2013.05.049 · Cited by 80
Liu, Z., Zhao, H., Shu, L., Zhang, Y., Okeke, C. I., Zhang, L., Li, J., & Li, N. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.861478 · Cited by 76
Learning from biology: synthetic lipoproteins for drug delivery
Huang, H., Cruz, W., Chen, J., & Zheng, G. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1308 · Cited by 75
Chen, W., Li, H., Liu, Z., & Yuan, W. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00068 · Cited by 75
Multiple sclerosis: Therapeutic applications of advancing drug delivery systems
Dolati, S., Babaloo, Z., Jadidi‐Niaragh, F., Ayromlou, H., Sadreddini, S., & Yousefi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.010 · Cited by 75
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
Patel, P. A., Patil, S. C., Kalaria, D. R., Kalia, Y. N., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.014 · Cited by 74
Potential applications of magnetic particles to detect and treat Alzheimer's disease
Busquets, M. A., Sabaté, R., & Estelrich, J. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-538 · Cited by 74
Fang, M., Jin, J., Bao, Gao, Xu, Wang, Wang, YAO, Y., & Liu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36257 · Cited by 73
Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization
Laserra, S., Basit, A., Sozio, P., Marinelli, L., Fornasari, E., Cacciatore, I., Ciulla, M., Türkez, H., Geyikoglu, F., & Di Stefano, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.001 · Cited by 72
Applications of Dendrimers for Brain Delivery and Cancer Therapy
Somani, S., & Dufès, C. (2014) · Nanomedicine · doi:10.2217/nnm.14.130 · Cited by 72
α-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles
Varkey, J., Mizuno, N., Hegde, B. G., Cheng, N., Steven, A. C., & Langen, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476697 · Cited by 71
Emami, J., Rezazadeh, M., Sadeghi, H., & Khadivar, K. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1189933 · Cited by 70
Synthetic High-Density Lipoprotein-Like Nanoparticles as Cancer Therapy
McMahon, K. M., Foit, L., Angeloni, N. L., Giles, F. J., Gordon, L. I., & Thaxton, C. S. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_6 · Cited by 69
Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism
Parhi, R., & Suresh, P. (2010) · Journal of chemical and pharmaceutical research · Cited by 68
Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells
Kuo, Y., & Liang, C.-T. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.02.011 · Cited by 64
Development of nanostructured lipid carrier for dacarbazine delivery
Almoussalam, M., Moia, C., & Zhu, H. (2015) · International nano letters. · doi:10.1007/s40089-015-0161-8 · Cited by 63
Antioxidative nanofullerol prevents intervertebral disk degeneration
Yang, X., Jin, L., Lu, Y., Shen, F. H., Shimer, A. L., & Li, X. J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s60853 · Cited by 63
Nanostructure-based drug delivery systems for brain targeting
Haque, S., Md, S., Alam, M. I., Sahni, J. K., Ali, J., & Baboota, S. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.608191 · Cited by 62
Liu, Z., Zhang, L., He, Q., Liu, X., Chukwunweike Ikechukwu, O., Tong, L., Guo, L., Yang, H., Zhang, Q., Zhao, H., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.049 · Cited by 62
Biomaterials for the Treatment of Alzheimer’s Disease
Hadavi, D., & Poot, A. A. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00049 · Cited by 61
The application of magnetic nanoparticles for the treatment of brain tumors
Mahmoudi, K., & Hadjipanayis, C. G. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00109 · Cited by 60
Hsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Chang, H., Yen, T., & Fang, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/40/405101 · Cited by 59
Dendrimers as Novel Systems for Delivery of Neuropharmaceuticals to the Brain
Beg, S., Samad, A., Alam, M. I., & Nazish, I. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711796235023 · Cited by 57
Song, Q., Chuan, X., Chen, B., He, B., Zhang, H., Dai, W., Wang, X., & Zhang, Q. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1028601 · Cited by 55
Niosomes of Ascorbic Acid and α-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats
Varshosaz, J., Taymouri, S., Pardakhty, A., Asadi‐Shekaari, M., & Babaee, A. (2014) · BioMed Research International · doi:10.1155/2014/816103 · Cited by 55
Meng, F., Asghar, S., Xu, Y., Wang, J., Jin, X., Wang, Z., Wang, J., Ping, Q., Zhou, J., & Xiao, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.033 · Cited by 55
Kuo, Y., & Wang, I.-H. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1132223 · Cited by 52
Micro- and Nanoparticles for Treating Cardiovascular Disease
Suarez, S. L., Almutairi, A., & Christman, K. (2015) · Biomaterials Science · doi:10.1039/c4bm00441h · Cited by 51
The potential of polymeric micelles in the context of glioblastoma therapy
Morshed, R. A., Cheng, Y., Auffinger, B., Wegscheid, M. L., & Lesniak, M. S. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00157 · Cited by 51
Chen, Z., Lai, X., Song, S., Zhu, X., & Zhu, J. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1038857 · Cited by 49
Spray drying of fenofibrate loaded nanostructured lipid carriers
Xia, D., Shrestha, N., van de Streek, J., Mu, H., & Yang, M. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.01.001 · Cited by 48
Khajavinia, A., Varshosaz, J., & Jafarian‐Dehkordi, A. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/40/405101 · Cited by 47
Gandomi, N., Varshochian, R., Atyabi, F., Ghahremani, M. H., Sharifzadeh, M. S., Amini, M., & Dinarvand, R. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1226901 · Cited by 46
Kuo, Y., & Lee, C. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.025 · Cited by 45
Functionalised collagen spheres reduce H2O2 mediated apoptosis by scavenging overexpressed ROS
Tapeinos, C., Larrañaga, A., Sarasua, J.-R., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.03.022 · Cited by 44
Self-citationKuo, Y., & Chao, I. (2015) · Biotechnology Progress · doi:10.1002/btpr.2214 · Cited by 43
Bernardi, A., Frozza, R. L., Hoppe, Salbego, Pohlmann, Battastini, A. M. O., & Guterres, S. S. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40284 · Cited by 40
Tapeinos, C., Efthimiadou, E. Κ., Boukos, N. K., Charitidis, C. A., Koklioti, M. A., & Kordas, G. C. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00013j · Cited by 40
Self-citationLee, C. Y., & Ooi, I. H. (2016) · Pharmaceuticals · doi:10.3390/ph9030054 · Cited by 40
Priano, L., Zara, G. P., Assawy, N. E., Cattaldo, S., Muntoni, E., Milano, E., Serpe, L., Musicanti, C., Pérot, C., Gasco, M. R., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.009 · Cited by 39
Kuo, Y., & Lee, C. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24388 · Cited by 39
Yang, Y., Yang, Y., Xie, X., Cai, X., & Mei, X. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.940589 · Cited by 38
Kuo, Y., & Lee, I.-H. (2016) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2015.12.012 · Cited by 38
Insights into Atherosclerosis Using Nanotechnology
Jayagopal, A., Linton, M. F., Fazio, S., & Haselton, F. R. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0106-7 · Cited by 36
Brain targeted solid lipid nanoparticles for brain ischemia: preparation andin vitrocharacterization
Morsi, N. M., Ghorab, D. M., & Badie, H. A. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2012.734513 · Cited by 35
Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers
Li, F., Wang, Y., Liu, Z., Lin, X., He, H., & Tang, X. (2009) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903264397 · Cited by 32
Efthimiadou, E. Κ., Tapeinos, C., Bilalis, P., & Kordas, G. C. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0579-5 · Cited by 31
Self-citationBizeau, J., Tapeinos, C., Marella, C., Larrañaga, A., & Pandit, A. S. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.07.081 · Cited by 31
Self-citationAntioxidant activity of idebenone-loaded neutral and cationic solid–lipid nanoparticles
Leonardi, A., Crascì, L., Panico, A., & Pignatello, R. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.915572 · Cited by 30
Liu, K., Wen, C.-J., Yen, T., Sung, K. C., Ku, M.-C., Wang, J., & Fang, J. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/9/095103 · Cited by 29
Efthimiadou, E. Κ., Tapeinos, C., Tziveleka, L., et al. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.01.024 · Cited by 28
Self-citationEfthimiadou, E. Κ., Tapeinos, C., Chatzipavlidis, A., Boukos, N. K., Fragogeorgi, E. A., Palamaris, L., Loudos, G. K., & Kordas, G. C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.037 · Cited by 25
Self-citationTapeinos, C., Efthimiadou, E. Κ., Boukos, N. K., & Kordas, G. C. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.019 · Cited by 24
Self-citationSharma, P., Dube, B., & Sawant, K. K. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.4235 · Cited by 22
Mandpe, L., Kyadarkunte, A., & Pokharkar, V. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.101 · Cited by 19
An acetal-based polymeric crosslinker with controlled pH-sensitivity
Cao, H., Dong, Y., Bré, L. P., Tapeinos, C., Wang, W., & Pandit, A. S. (2016) · RSC Advances · doi:10.1039/c6ra00423g · Cited by 15
Self-citationNew nanomedicines for treating atherosclerotic plaques
Sargent, J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.35 · Cited by 11
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Recent advancements in liposome technology
Filipczak, N., Pan, J., Yalamarty, S. S. K., & Torchilin, V. P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.022 · Cited by 592
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Metadata
- Authors
- Tapeinos, C., Battaglini, M., & Ciofani, G.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 264
- Pages
- 306-332
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2746957719
- Cited by
- 539
- References
- 172
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.